The Effect of Probiotics on Symptoms of Infantile Colic

Last updated: February 8, 2022
Sponsor: Lallemand Health Solutions
Overall Status: Active - Recruiting

Phase

2

Condition

Colic

Treatment

N/A

Clinical Study ID

NCT05198700
L-022
  • Ages < 8
  • All Genders

Study Summary

The aim of this study is to evaluate the effects of a probiotic formulation on the daily crying patterns of infants. It is hypothesized that participants given the probiotic formulation will show a significant reduction in daily crying duration compared to participants receiving the placebo.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Healthy male or female.
  2. Age ≤ 8 weeks old.
  3. Diagnosis of infantile colic according to the Rome IV criteria. Infants must show cryor fuss behaviour for 3 or more hours per day, during 3 or more days in 7 days.
  4. Exclusively breastfeeding and planning to breastfeed for duration of study.
  5. With a written informed consent signed by the father, mother, or legal guardian, andwith expressed or implied consent of the other parent.
  6. With parents willing to complete questionnaires, records, and diaries associated tothe study and to complete all clinical visits and telephone calls.

Exclusion

Exclusion Criteria:

  1. Birthweight < 2500 g.
  2. Gestational age < 37 weeks.
  3. Apgar score at 5 minutes < 7.
  4. Partially or fully formula fed infants, with the exception of the first 4 days afterbirth.
  5. Stunted growth/weight loss (< 100 g/week from birth to last reported).
  6. Gastroesophageal reflux disease, short bowel syndrome, chronic intestinal diseases orgastrointestinal malformations.
  7. Fever and/or infectious diseases, or current systemic infections, or history ofcongenital infections.
  8. Genetic diseases and chromosomal abnormalities.
  9. Metabolic diseases or pancreatic insufficiency.
  10. Immunodeficiency.
  11. Neurological diseases.
  12. Suspected or confirmed food allergies and intolerances.
  13. Use of probiotics, prebiotics, antibiotics, or gastric acid inhibitors by the infantat any time from birth to the moment of screening.
  14. Use of anti-colic medication at any time from birth to the moment of screening.
  15. Use of probiotic supplements by the mother between the birth of their infant and themoment of screening.
  16. Currently enrolled in another clinical study or having participated in anotherclinical trial from birth to the moment of screening.

Study Design

Total Participants: 70
Study Start date:
February 01, 2022
Estimated Completion Date:
April 30, 2023

Study Description

Participants diagnosed with symptoms of infantile colic will be recruited to participate in this randomized, double-blind, placebo-controlled, two-arm parallel study. Eligible participants will be enrolled in this study for 6 weeks, and will undergo a 1-week run-in baseline period followed by a 4-week interventional period, then a 1-week follow-up period.

The study will consist of 7 visits (V0 to V6): 4 in-person visits that alternate with 3 phone calls.

Connect with a study center

  • Centro de Salud Cerro del Aire

    Majadahonda, Madrid 28220
    Spain

    Active - Recruiting

  • Centro de Salud Campo de la Paloma

    Madrid, 28018
    Spain

    Active - Recruiting

  • Centro de Salud Ibiza

    Madrid, 28009
    Spain

    Active - Recruiting

  • Hospital Vithas Aravaca

    Madrid, 28023
    Spain

    Active - Recruiting

  • Hospital Vithas La Milagrosa

    Madrid, 28010
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.